Guardian Bio is a cancer therapeutics platform creating the next generation of cell therapies to tackle solid tumors. Our cell therapies are based off of recently defined conventional dendritic cells (cDCs) and have a full toolkit to both activate and redirect a diverse range of immune cells against multiple tumor antigens. Our goal is to bring immunotherapy to a new world of patients.
- Ananya Zutshi CEO
- Richard Barrett CSO